Arcturus Therapeutics Holdings ARCT
NASDAQ ARCT
$15.82 +0.26 (+1.67%)
As of: Sep 4, 2026 · 3:59 PM EDT

Arcturus Therapeutics Holdings (ARCT) Prepaid Assets (2018 - 2026)

Arcturus Therapeutics Holdings' (ARCT) quarterly Prepaid Assets came in at $4.2 million in Q1 2026, down 52.54% YoY from $8.8 million in Q1 2025, and down 16.27% on a QoQ basis from $5.0 million in Q4 2025.

Analysis

Arcturus Therapeutics Holdings (ARCT) Prepaid Assets (2018 - 2026) Analysis & Trends

Arcturus Therapeutics Holdings (ARCT) has 9 years of Prepaid Assets data on file, last reported at $4.2 million in Q1 2026.

  • Quarterly Prepaid Assets fell 52.54% year-over-year to $4.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.2 million (down 52.54% YoY) and the FY2025 annual result came in at $5.0 million, down 50.16% from the prior year.
  • Prepaid Assets slipped to $4.2 million in Q1 2026, from $5.0 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $10.0 million in Q4 2024 to a low of $3.6 million in Q1 2022.
  • A 5-year average of $6.5 million and a median of $5.9 million in 2025 frame the typical range for Prepaid Assets.
  • Annual changes were most pronounced in 2022 — Prepaid Assets jumped 216.17% — and 2026, when it sank 52.54%.
  • Tracing ARCT's Prepaid Assets over 5 years: stood at $8.7 million in 2022, then fell by 13.41% to $7.5 million in 2023, then surged by 32.66% to $10.0 million in 2024, then slumped by 50.16% to $5.0 million in 2025, then dropped by 16.27% to $4.2 million in 2026.
  • The last three Prepaid Assets figures came in at $4.2 million (Q1 2026), $5.0 million (Q4 2025), and $5.9 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Arcturus Therapeutics Holdings 449.65 Mn 258.17 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.87 Mn
Mar 31, 2026 4.16 Mn
Dec 31, 2025 4.97 Mn
Sep 30, 2025 5.89 Mn
Jun 30, 2025 5.83 Mn
Mar 31, 2025 8.77 Mn
Dec 31, 2024 9.98 Mn
Sep 30, 2024 8.44 Mn
Jun 30, 2024 7.59 Mn
Mar 31, 2024 5.34 Mn
Dec 31, 2023 7.52 Mn
Sep 30, 2023 8.13 Mn
Jun 30, 2023 3.97 Mn
Mar 31, 2023 4.14 Mn
Dec 31, 2022 8.69 Mn
Sep 30, 2022 6.96 Mn
Jun 30, 2022 5.77 Mn
Mar 31, 2022 3.64 Mn
Dec 31, 2021 5.10 Mn
Sep 30, 2021 5.07 Mn